Studies have demonstrated that tumor cells that have either been transfected with granulocyte-macrophage colony stimulating factor (GM-CSF) genes, alone or in combination with biodegradable GM-CSF capsules, can induce specific immune responses both in vitro and in vivo [253,254]. Here, CSF2 is linked to neoplasm.